Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 76

Related Articles by Review for PubMed (Select 15322265)

3.

Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons.

Guillot TS, Miller GW.

Mol Neurobiol. 2009 Apr;39(2):149-70. doi: 10.1007/s12035-009-8059-y. Epub 2009 Mar 4. Review.

PMID:
19259829
4.

A pharmacological analysis of mice with a targeted disruption of the serotonin transporter.

Fox MA, Andrews AM, Wendland JR, Lesch KP, Holmes A, Murphy DL.

Psychopharmacology (Berl). 2007 Dec;195(2):147-66. Epub 2007 Aug 22. Review.

PMID:
17712549
5.

Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity.

Fleckenstein AE, Gibb JW, Hanson GR.

Eur J Pharmacol. 2000 Oct 6;406(1):1-13. Review.

PMID:
11011026
6.

Experimental gene interaction studies with SERT mutant mice as models for human polygenic and epistatic traits and disorders.

Murphy DL, Uhl GR, Holmes A, Ren-Patterson R, Hall FS, Sora I, Detera-Wadleigh S, Lesch KP.

Genes Brain Behav. 2003 Dec;2(6):350-64. Review.

PMID:
14653307
7.

Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules.

Henry JP, Botton D, Sagne C, Isambert MF, Desnos C, Blanchard V, Raisman-Vozari R, Krejci E, Massoulie J, Gasnier B.

J Exp Biol. 1994 Nov;196:251-62. Review.

8.

The VMAT2 gene in mice and humans: amphetamine responses, locomotion, cardiac arrhythmias, aging, and vulnerability to dopaminergic toxins.

Uhl GR, Li S, Takahashi N, Itokawa K, Lin Z, Hazama M, Sora I.

FASEB J. 2000 Dec;14(15):2459-65. Review.

9.

[Genetic models to understand how serotonin acts during development].

Gaspar P.

J Soc Biol. 2004;198(1):18-21. Review. French.

PMID:
15146951
10.

[Function of monoamine neurotransmitter transporters].

Sasa M.

Nihon Rinsho. 2001 Aug;59(8):1457-64. Review. Japanese.

PMID:
11519142
11.

Monoamine transporter as a target molecule for psychostimulants.

Sora I, Li B, Fumushima S, Fukui A, Arime Y, Kasahara Y, Tomita H, Ikeda K.

Int Rev Neurobiol. 2009;85:29-33. doi: 10.1016/S0074-7742(09)85003-4. Review.

PMID:
19607959
12.

Regulation of the serotonin transporter by interacting proteins.

Haase J, Killian AM, Magnani F, Williams C.

Biochem Soc Trans. 2001 Nov;29(Pt 6):722-8. Review.

PMID:
11709063
13.
14.

Human phenotypes and animal knockout models of genetic autonomic disorders.

Usera PC, Vincent S, Robertson D.

J Biomed Sci. 2004 Jan-Feb;11(1):4-10. Review.

PMID:
14730204
15.

Structure, function and regulation of the 5-hydroxytryptamine (serotonin) transporter.

Horschitz S, Hummerich R, Schloss P.

Biochem Soc Trans. 2001 Nov;29(Pt 6):728-32. Review.

PMID:
11709064
16.

Dopamine transporters and neuronal injury.

Miller GW, Gainetdinov RR, Levey AI, Caron MG.

Trends Pharmacol Sci. 1999 Oct;20(10):424-9. Review.

PMID:
10498956
17.

Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease.

Watanabe Y, Himeda T, Araki T.

Med Sci Monit. 2005 Jan;11(1):RA17-23. Review.

PMID:
15614202
18.

Physiological genomics of antidepressant targets: keeping the periphery in mind.

Blakely RD.

J Neurosci. 2001 Nov 1;21(21):8319-23. Review.

19.

[Pharmacology of monoamine neurotransmitter transporters].

Dohi T, Kitayama S, Kumagai K, Hashimoto W, Morita K.

Nihon Yakurigaku Zasshi. 2002 Nov;120(5):315-26. Review. Japanese.

PMID:
12491807
20.

Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins.

Blakely RD, Ramamoorthy S, Schroeter S, Qian Y, Apparsundaram S, Galli A, DeFelice LJ.

Biol Psychiatry. 1998 Aug 1;44(3):169-78. Review.

PMID:
9693389
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk